BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagrath D, Xu H, Tanimura Y, Zuo R, Berthiaume F, Avila M, Yarmush R, Yarmush ML. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng. 2009;11:274-283. [PMID: 19508897 DOI: 10.1016/j.ymben.2009.05.005] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Magro B, Tacelli M, Mazzola A, Conti F, Celsa C. Biliary complications after liver transplantation: current perspectives and future strategies. Hepatobiliary Surg Nutr 2021;10:76-92. [PMID: 33575291 DOI: 10.21037/hbsn.2019.09.01] [Reference Citation Analysis]
2 Detelich D, Markmann JF. The dawn of liver perfusion machines. Curr Opin Organ Transplant 2018;23:151-61. [PMID: 29324518 DOI: 10.1097/MOT.0000000000000500] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
3 Bruinsma BG, Yarmush ML, Uygun K. Organomatics and organometrics: Novel platforms for long-term whole-organ culture. Technology (Singap World Sci) 2014;2:13. [PMID: 25035864 DOI: 10.1142/S2339547814300029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Bae C, Henry SD, Guarrera JV. Is extracorporeal hypothermic machine perfusion of the liver better than the ‘good old icebox’?: . Current Opinion in Organ Transplantation 2012;17:137-42. [DOI: 10.1097/mot.0b013e328351083d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
5 Nativ NI, Maguire TJ, Yarmush G, Brasaemle DL, Henry SD, Guarrera JV, Berthiaume F, Yarmush ML. Liver defatting: an alternative approach to enable steatotic liver transplantation. Am J Transplant. 2012;12:3176-3183. [PMID: 23057797 DOI: 10.1111/j.1600-6143.2012.04288.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
6 Nösser M, Gassner JMGV, Moosburner S, Wyrwal D, Claussen F, Hillebrandt KH, Horner R, Tang P, Reutzel-selke A, Polenz D, Arsenic R, Pratschke J, Sauer IM, Raschzok N. Development of a Rat Liver Machine Perfusion System for Normothermic and Subnormothermic Conditions. Tissue Engineering Part A 2020;26:57-65. [DOI: 10.1089/ten.tea.2019.0152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
7 Xu J, Buchwald JE, Martins PN. Review of Current Machine Perfusion Therapeutics for Organ Preservation. Transplantation 2020;104:1792-803. [PMID: 32371846 DOI: 10.1097/TP.0000000000003295] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 13.0] [Reference Citation Analysis]
8 Ceresa CDL, Nasralla D, Knight S, Friend PJ. Cold storage or normothermic perfusion for liver transplantation: probable application and indications. Curr Opin Organ Transplant. 2017;22:300-305. [PMID: 28301388 DOI: 10.1097/mot.0000000000000410] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
9 Richards JA, Randle LV, Butler MChir AJ, Martin JL, Fedotovs A, Davies SE, Watson CJE, Robertson PA. Pilot study of a noninvasive real-time optical backscatter probe in liver transplantation. Transpl Int 2021;34:709-20. [PMID: 33462839 DOI: 10.1111/tri.13823] [Reference Citation Analysis]
10 Fontes P, Lopez R, van der Plaats A, Vodovotz Y, Minervini M, Scott V, Soltys K, Shiva S, Paranjpe S, Sadowsky D, Barclay D, Zamora R, Stolz D, Demetris A, Michalopoulos G, Marsh JW. Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions. Am J Transplant. 2015;15:381-394. [PMID: 25612645 DOI: 10.1111/ajt.12991] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 13.2] [Reference Citation Analysis]
11 Karangwa SA, Dutkowski P, Fontes P, Friend PJ, Guarrera JV, Markmann JF, Mergental H, Minor T, Quintini C, Selzner M, Uygun K, Watson CJ, Porte RJ. Machine Perfusion of Donor Livers for Transplantation: A Proposal for Standardized Nomenclature and Reporting Guidelines. Am J Transplant. 2016;16:2932-2942. [PMID: 27129409 DOI: 10.1111/ajt.13843] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 15.0] [Reference Citation Analysis]
12 Taba Taba Vakili S, Kailar R, Rahman K, Nezami BG, Mwangi SM, Anania FA, Srinivasan S. Glial cell line-derived neurotrophic factor-induced mice liver defatting: A novel strategy to enable transplantation of steatotic livers. Liver Transpl. 2016;22:459-467. [PMID: 26714616 DOI: 10.1002/lt.24385] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
13 Ghinolfi D, Rreka E, Pezzati D, Filipponi F, De Simone P. Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease? Transl Gastroenterol Hepatol 2017;2:87. [PMID: 29264425 DOI: 10.21037/tgh.2017.10.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Petrowsky H, Clavien P. Principles of Liver Preservation. Transplantation of the Liver. Elsevier; 2015. pp. 582-99. [DOI: 10.1016/b978-1-4557-0268-8.00044-0] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
15 Green CJ, Parry SA, Gunn PJ, Ceresa CDL, Rosqvist F, Piché ME, Hodson L. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. Horm Mol Biol Clin Investig 2018;41:/j/hmbci. [PMID: 30098284 DOI: 10.1515/hmbci-2018-0038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
16 Parente A, Osei-Bordom DC, Ronca V, Perera MTPR, Mirza D. Organ Restoration With Normothermic Machine Perfusion and Immune Reaction. Front Immunol 2020;11:565616. [PMID: 33193335 DOI: 10.3389/fimmu.2020.565616] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 de Vries RJ, Yarmush M, Uygun K. Systems engineering the organ preservation process for transplantation. Curr Opin Biotechnol 2019;58:192-201. [PMID: 31280087 DOI: 10.1016/j.copbio.2019.05.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
18 Jayant K, Reccia I, Shapiro AJ. Normothermic ex-vivo liver perfusion: where do we stand and where to reach? Expert Review of Gastroenterology & Hepatology 2018;12:1045-58. [DOI: 10.1080/17474124.2018.1505499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Dengu F, Abbas SH, Ebeling G, Nasralla D. Normothermic Machine Perfusion (NMP) of the Liver as a Platform for Therapeutic Interventions during Ex-Vivo Liver Preservation: A Review. J Clin Med. 2020;9. [PMID: 32272760 DOI: 10.3390/jcm9041046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
20 Ravikumar R, Leuvenink H, Friend PJ. Normothermic liver preservation: a new paradigm? Transpl Int. 2015;28:690-699. [PMID: 25847684 DOI: 10.1111/tri.12576] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 9.8] [Reference Citation Analysis]
21 Hefler J, Marfil-garza BA, Dadheech N, Shapiro AJ. Machine Perfusion of the Liver: Applications Beyond Transplantation. Transplantation 2020;104:1804-12. [DOI: 10.1097/tp.0000000000003320] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Kvietkauskas M, Leber B, Strupas K, Stiegler P, Schemmer P. Machine Perfusion of Extended Criteria Donor Organs: Immunological Aspects. Front Immunol 2020;11:192. [PMID: 32180769 DOI: 10.3389/fimmu.2020.00192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
23 Bral M, Shapiro AMJ. Normothermic Preservation of Liver – What Does the Future Hold? In: Turksen K, editor. Cell Biology and Translational Medicine, Volume 9. Cham: Springer International Publishing; 2020. pp. 13-31. [DOI: 10.1007/5584_2020_517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Raigani S, Carroll C, Griffith S, Pendexter C, Rosales I, Deirawan H, Beydoun R, Yarmush M, Uygun K, Yeh H. Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content. PLoS One 2020;15:e0232886. [PMID: 32396553 DOI: 10.1371/journal.pone.0232886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
25 Akateh C, Beal EW, Whitson BA, Black SM. Normothermic Ex-vivo Liver Perfusion and the Clinical Implications for Liver Transplantation. J Clin Transl Hepatol 2018;6:276-82. [PMID: 30271739 DOI: 10.14218/JCTH.2017.00048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
26 Ward A, Klassen DK, Franz KM, Giwa S, Lewis JK. Social, economic, and policy implications of organ preservation advances. Curr Opin Organ Transplant 2018;23:336-46. [PMID: 29683801 DOI: 10.1097/MOT.0000000000000532] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
27 Liu Q, Berendsen T, Izamis ML, Uygun B, Yarmush ML, Uygun K. Perfusion defatting at subnormothermic temperatures in steatotic rat livers. Transplant Proc. 2013;45:3209-3213. [PMID: 24182786 DOI: 10.1016/j.transproceed.2013.05.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
28 Linares I, Hamar M, Selzner N, Selzner M. Steatosis in Liver Transplantation: Current Limitations and Future Strategies. Transplantation 2019;103:78-90. [DOI: 10.1097/tp.0000000000002466] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 15.5] [Reference Citation Analysis]
29 Ceresa CDL, Nasralla D, Jassem W. Normothermic Machine Preservation of the Liver: State of the Art.Curr Transplant Rep. 2018;5:104-110. [PMID: 29564207 DOI: 10.1007/s40472-018-0186-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
30 Buchwald JE, Xu J, Bozorgzadeh A, Martins PN. Therapeutics administered during ex vivo liver machine perfusion: An overview. World J Transplant 2020;10:1-14. [PMID: 32110510 DOI: 10.5500/wjt.v10.i1.1] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
31 Yarmush G, Santos L, Yarmush J, Koundinyan S, Saleem M, Nativ NI, Yarmush ML, Berthiaume F, Maguire TJ, Guaghan C. CFD assessment of the effect of convective mass transport on the intracellular clearance of intracellular triglycerides in macrosteatotic hepatocytes. Biomech Model Mechanobiol 2017;16:1095-102. [DOI: 10.1007/s10237-017-0882-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Jamieson RW, Zilvetti M, Roy D, Hughes D, Morovat A, Coussios CC, Friend PJ. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model. Transplantation. 2011;92:289-295. [PMID: 21681143 DOI: 10.1097/tp.0b013e318223d817] [Cited by in Crossref: 102] [Cited by in F6Publishing: 36] [Article Influence: 10.2] [Reference Citation Analysis]
33 Izamis ML, Calhoun C, Uygun BE, Guzzardi MA, Price G, Luitje M, Saeidi N, Yarmush ML, Uygun K. SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS. Cell Med 2013;4:109-23. [PMID: 25431743 DOI: 10.3727/215517912X658927] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
34 Tolboom H, Izamis ML, Sharma N, Milwid JM, Uygun B, Berthiaume F, Uygun K, Yarmush ML. Subnormothermic machine perfusion at both 20°C and 30°C recovers ischemic rat livers for successful transplantation. J Surg Res. 2012;175:149-156. [PMID: 21550058 DOI: 10.1016/j.jss.2011.03.003] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 7.0] [Reference Citation Analysis]
35 Nebrig M, Neuhaus P, Pascher A. Advances in the management of the explanted donor liver. Nat Rev Gastroenterol Hepatol 2014;11:489-96. [DOI: 10.1038/nrgastro.2014.58] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
36 Sexton D, Medearis S, Liu Q, Iuppa G, Quintini C. Preclinical Foundation for Normothermic Machine Liver Preservation. Curr Transpl Rep 2015;2:68-73. [DOI: 10.1007/s40472-014-0037-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Jayant K, Reccia I, Virdis F, Shapiro AMJ. The Role of Normothermic Perfusion in Liver Transplantation (TRaNsIT Study): A Systematic Review of Preliminary Studies. HPB Surg. 2018;2018:6360423. [PMID: 29887782 DOI: 10.1155/2018/6360423] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
38 Liu Q, Nassar A, Buccini L, Iuppa G, Soliman B, Pezzati D, Hassan A, Blum M, Baldwin W, Bennett A, Chavin K, Okamoto T, Uso TD, Fung J, Abu-elmagd K, Miller C, Quintini C. Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transpl 2018;24:233-45. [DOI: 10.1002/lt.24972] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
39 Boteon YL, Boteon APCS, Attard J, Mergental H, Mirza DF, Bhogal RH, Afford SC. Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review. Am J Transplant. 2018;18:2384-2399. [PMID: 29947472 DOI: 10.1111/ajt.14992] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
40 Aoudjehane L, Gautheron J, Le Goff W, Goumard C, Gilaizeau J, Nget CS, Savier E, Atif M, Lesnik P, Morichon R, Chrétien Y, Calmus Y, Scatton O, Housset C, Conti F. Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis. Dis Model Mech 2020;13:dmm042663. [PMID: 32094147 DOI: 10.1242/dmm.042663] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
41 Rampes S, Ma D. Hepatic ischemia-reperfusion injury in liver transplant setting: mechanisms and protective strategies. J Biomed Res 2019;33:221-34. [PMID: 32383437 DOI: 10.7555/JBR.32.20180087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
42 Rezania V, Coombe D, Tuszynski J. Liver Bioreactor Design Issues of Fluid Flow and Zonation, Fibrosis, and Mechanics: A Computational Perspective. J Funct Biomater 2020;11:E13. [PMID: 32121053 DOI: 10.3390/jfb11010013] [Reference Citation Analysis]
43 Lin F, Zhen F, Yan X, Shaojun Y, Guizhu P, Yanfeng W, Qifa Y. Hypothermic oxygenated perfusion with defatting cocktail further improves steatotic liver grafts in a transplantation rat model. Artif Organs 2021;45:E304-16. [PMID: 33908066 DOI: 10.1111/aor.13976] [Reference Citation Analysis]
44 Wang S, Nagrath D. Liver Tissue Engineering. In: Burdick JA, Mauck RL, editors. Biomaterials for Tissue Engineering Applications. Vienna: Springer; 2011. pp. 389-419. [DOI: 10.1007/978-3-7091-0385-2_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Mazilescu LI, Selzner M, Selzner N. Defatting strategies in the current era of liver steatosis. JHEP Rep 2021;3:100265. [PMID: 34027337 DOI: 10.1016/j.jhepr.2021.100265] [Reference Citation Analysis]
46 Hessheimer AJ, Fondevila C. Liver perfusion devices: how close are we to widespread application? Current Opinion in Organ Transplantation 2017;22:105-11. [DOI: 10.1097/mot.0000000000000384] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
47 Goumard C, Turco C, Sakka M, Aoudjehane L, Lesnik P, Savier E, Conti F, Scatton O. Ex-Vivo Pharmacological Defatting of the Liver: A Review.J Clin Med. 2021;10:1253. [PMID: 33803539 DOI: 10.3390/jcm10061253] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Badawy A, Kaido T, Uemoto S. Current Status of Liver Transplantation Using Marginal Grafts. Journal of Investigative Surgery 2020;33:553-64. [DOI: 10.1080/08941939.2018.1517197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
49 Nativ NI, Yarmush G, So A, Barminko J, Maguire TJ, Schloss R, Berthiaume F, Yarmush ML. Elevated sensitivity of macrosteatotic hepatocytes to hypoxia/reoxygenation stress is reversed by a novel defatting protocol. Liver Transpl. 2014;20:1000-1011. [PMID: 24802973 DOI: 10.1002/lt.23905] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
50 Desai CS, Gerber DA. Concise review of machine perfusion in liver transplantation. World J Hepatol 2020;12:6-9. [PMID: 31984116 DOI: 10.4254/wjh.v12.i1.6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
51 Tchilikidi KY. Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion. World J Gastrointest Surg 2019;11:126-42. [PMID: 31057698 DOI: 10.4240/wjgs.v11.i3.126] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
52 Boteon YL, Wallace L, Boteon APCS, Mirza DF, Mergental H, Bhogal RH, Afford S. An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells. PLoS One. 2018;13:e0201419. [PMID: 30044872 DOI: 10.1371/journal.pone.0201419] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
53 Yarmush G, Santos L, Yarmush J, Koundinyan S, Saleem M, Nativ NI, Schloss RS, Yarmush ML, Maguire TJ, Berthiaume F. Metabolic Flux Distribution during Defatting of Steatotic Human Hepatoma (HepG2) Cells. Metabolites 2016;6:E1. [PMID: 26742084 DOI: 10.3390/metabo6010001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
54 Liu Q, Izamis ML, Xu H, Berendsen T, Yarmush M, Uygun K. Strategies to rescue steatotic livers before transplantation in clinical and experimental studies. World J Gastroenterol. 2013;19:4638-4650. [PMID: 23922462 DOI: 10.3748/wjg.v19.i29.4638] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
55 Raigani S, De Vries RJ, Uygun K, Yeh H. Pumping new life into old ideas: Preservation and rehabilitation of the liver using ex situ machine perfusion. Artif Organs 2020;44:123-8. [PMID: 31691326 DOI: 10.1111/aor.13579] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Aufhauser DD Jr, Foley DP. Beyond Ice and the Cooler: Machine Perfusion Strategies in Liver Transplantation. Clin Liver Dis 2021;25:179-94. [PMID: 33978577 DOI: 10.1016/j.cld.2020.08.013] [Reference Citation Analysis]
57 Pais R, Barritt AS 4th, Calmus Y, Scatton O, Runge T, Lebray P, Poynard T, Ratziu V, Conti F. NAFLD and liver transplantation: Current burden and expected challenges. J Hepatol. 2016;65:1245-1257. [PMID: 27486010 DOI: 10.1016/j.jhep.2016.07.033] [Cited by in Crossref: 190] [Cited by in F6Publishing: 155] [Article Influence: 38.0] [Reference Citation Analysis]
58 Sharma NS, Nagrath D, Yarmush ML. Adipocyte-derived basement membrane extract with biological activity: applications in hepatocyte functional augmentation in vitro. FASEB J 2010;24:2364-74. [PMID: 20233948 DOI: 10.1096/fj.09-135095] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
59 Selten J, Schlegel A, de Jonge J, Dutkowski P. Hypo- and normothermic perfusion of the liver: Which way to go? Best Pract Res Clin Gastroenterol. 2017;31:171-179. [PMID: 28624105 DOI: 10.1016/j.bpg.2017.04.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
60 Detelich D, Markmann JF. Normothermic liver preservation, current status and future directions. Curr Opin Organ Transplant 2018;23:347-52. [PMID: 29629996 DOI: 10.1097/MOT.0000000000000531] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
61 Pinezich M, Vunjak-Novakovic G. Bioengineering approaches to organ preservation ex vivo. Exp Biol Med (Maywood) 2019;244:630-45. [PMID: 30889963 DOI: 10.1177/1535370219834498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
62 Gao J, He K, Xia Q, Zhang J. Research progress on hepatic machine perfusion. Int J Med Sci 2021;18:1953-9. [PMID: 33850464 DOI: 10.7150/ijms.56139] [Reference Citation Analysis]
63 Golse N, Cosse C, Allard MA, Laurenzi A, Tedeschi M, Guglielmo N, Fernandez-Sevilla E, Robert M, Tréchot B, Pietrasz D, Pittau G, Ciacio O, Sa Cunha A, Castaing D, Cherqui D, Adam R, Samuel D, Sebagh M, Vibert E. Evaluation of a micro-spectrometer for the real-time assessment of liver graft with mild-to-moderate macrosteatosis: A proof of concept study. J Hepatol 2019;70:423-30. [PMID: 30399385 DOI: 10.1016/j.jhep.2018.10.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
64 Haga S, YiMin, Yamaki H, Jin S, Sogon T, Morita N, Ozaki M. Extracts of bilberry (Vaccinium myrtillus L.) fruits improve liver steatosis and injury in mice by preventing lipid accumulation and cell death. Biosci Biotechnol Biochem 2019;83:2110-20. [PMID: 31244392 DOI: 10.1080/09168451.2019.1634514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Croome KP, Lee DD, Croome S, Chadha R, Livingston D, Abader P, Keaveny AP, Taner CB. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis. Am J Transplant 2019;19:2550-9. [DOI: 10.1111/ajt.15330] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
66 Eymard C, Markmann J. Normothermic ex vivo liver perfusion: platform for liver graft assessment and therapeutic modification. Organogenesis 2018;14:169-71. [PMID: 30289350 DOI: 10.1080/15476278.2018.1517564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Bejaoui M, Pantazi E, Folch-Puy E, Baptista PM, García-Gil A, Adam R, Roselló-Catafau J. Emerging concepts in liver graft preservation. World J Gastroenterol. 2015;21:396-407. [PMID: 25593455 DOI: 10.3748/wjg.v21.i2.396] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
68 Baidya R, Crawford DHG, Gautheron J, Wang H, Bridle KR. Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury. Int J Mol Sci 2020;21:E5931. [PMID: 32824744 DOI: 10.3390/ijms21165931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
69 Nagrath D, Caneba C, Karedath T, Bellance N. Metabolomics for mitochondrial and cancer studies. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2011;1807:650-63. [DOI: 10.1016/j.bbabio.2011.03.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
70 Gilbo N, Catalano G, Salizzoni M, Romagnoli R. Liver graft preconditioning, preservation and reconditioning. Digestive and Liver Disease 2016;48:1265-74. [DOI: 10.1016/j.dld.2016.06.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
71 Boteon YL, Attard J, Boteon APCS, Wallace L, Reynolds G, Hubscher S, Mirza DF, Mergental H, Bhogal RH, Afford SC. Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery. Liver Transpl. 2019;25:1007-1022. [PMID: 30821045 DOI: 10.1002/lt.25439] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 43.0] [Reference Citation Analysis]
72 Xu M, Zhou F, Ahmed O, Upadhya GA, Jia J, Lee C, Xing J, Ye L, Shim SH, Zhang Z, Byrnes K, Wong B, Kim JS, Lin Y, Chapman WC. A Novel Multidrug Combination Mitigates Rat Liver Steatosis Through Activating AMPK Pathway During Normothermic Machine Perfusion. Transplantation 2021. [PMID: 34019362 DOI: 10.1097/TP.0000000000003675] [Reference Citation Analysis]
73 Wertheim JA. Novel technology for liver regeneration and replacement. Liver Transpl 2016;22:41-6. [PMID: 27611337 DOI: 10.1002/lt.24635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Weissenbacher A, Vrakas G, Nasralla D, Ceresa CDL. The future of organ perfusion and re-conditioning.Transpl Int. 2019;32:586-597. [PMID: 30980772 DOI: 10.1111/tri.13441] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
75 Oldhafer F, Beetz O, Cammann S, Richter N, Klempnauer J, Vondran FWR. [Machine Perfusion for Liver Transplantation - What is Possible and Where Do We Stand in Germany? Review of the Literature and Results of a National Survey]. Zentralbl Chir 2021;146:382-91. [PMID: 33761573 DOI: 10.1055/a-1363-2520] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Gilbo N, Monbaliu D. Temperature and oxygenation during organ preservation: friends or foes? Curr Opin Organ Transplant 2017;22:290-9. [PMID: 28426449 DOI: 10.1097/MOT.0000000000000416] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
77 Ceresa CDL, Nasralla D, Coussios CC, Friend PJ. The case for normothermic machine perfusion in liver transplantation. Liver Transpl 2018;24:269-75. [PMID: 29272051 DOI: 10.1002/lt.25000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
78 Hamar M, Selzner M. Steatotic donor livers: Where is the risk-benefit maximized?: Hamar and Selzner. Liver Transpl 2017;23:S34-9. [DOI: 10.1002/lt.24826] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
79 Kunst RF, Niemeijer M, van der Laan LJW, Spee B, van de Graaf SFJ. From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease. Biochem Pharmacol 2020;180:114173. [PMID: 32717228 DOI: 10.1016/j.bcp.2020.114173] [Reference Citation Analysis]
80 Lembach Jahnsen H, Mergental H, Perera MTPR, Mirza DF. Ex-situ liver preservation with machine preservation. Curr Opin Organ Transplant 2021;26:121-32. [PMID: 33650995 DOI: 10.1097/MOT.0000000000000864] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Beal EW, Dumond C, Kim JL, Akateh C, Eren E, Maynard K, Sen CK, Zweier JL, Washburn K, Whitson BA, Black SM. A Small Animal Model of Ex Vivo Normothermic Liver Perfusion. J Vis Exp 2018. [PMID: 30010635 DOI: 10.3791/57541] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
82 Raigani S, Markmann JF, Yeh H. Rehabilitation of Discarded Steatotic Livers Using Ex Situ Normothermic Machine Perfusion: A Future Source of Livers for Transplantation. Liver Transpl. 2019;25:991-992. [PMID: 31077626 DOI: 10.1002/lt.25490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
83 Nativ NI, Yarmush G, Chen A, Dong D, Henry SD, Guarrera JV, Klein KM, Maguire T, Schloss R, Berthiaume F, Yarmush ML. Rat hepatocyte culture model of macrosteatosis: effect of macrosteatosis induction and reversal on viability and liver-specific function. J Hepatol 2013;59:1307-14. [PMID: 23872604 DOI: 10.1016/j.jhep.2013.07.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
84 Bejaoui M, Pantazi E, De Luca V, Panisello A, Folch-puy E, Serafin A, Capasso C, C. T. S, Rosselló-catafau J. Acetazolamide Protects Steatotic Liver Grafts against Cold Ischemia Reperfusion Injury. J Pharmacol Exp Ther 2015;355:191-8. [DOI: 10.1124/jpet.115.225177] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
85 Croome KP, Lee DD, Taner CB. The “Skinny” on Assessment and Utilization of Steatotic Liver Grafts: A Systematic Review: Liver Transplantation. Liver Transpl 2019;25:488-99. [DOI: 10.1002/lt.25408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]